IMAPRB - INVERNESS MEDICAL INNOVATIONS PFDCONVSERB
This page shows which of the focused investors we track hold IMAPRB and how their positions changed, so you can see how much conviction the group has in the stock.
In Q4 2009 it was held by 1 manager with an aggregate reported value of $12.67M, which is 0.01% of the combined portfolio.
As of Q4 2009, 1 tracked institutional manager held IMAPRB (INVERNESS MEDICAL INNOVATIONS PFDCONVSERB) with an aggregate reported value of $12.67M — 0.01% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades IMAPRB — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q4 2009
- Ticker
- IMAPRB
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | ValueAct Capital - ValueAct Capital | 0.50% | New | 47,195 | $12.67M |
Loading holder history for IMAPRB…